Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Digestive Diseases and Sciences|May 23, 2014
Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent mannerJunru Wang, Junying Zheng, Ashwini Kulkarni, et al.
Neuroscience Letters|March 1, 2018
Pinprick hypo- and hyperalgesia in diabetic rats: Can diet content affect experimental outcome?Jai Shankar K Yadlapalli, Navdeep Dogra, Anqi W Walbaum, et al.
Life Sciences|December 2, 2017
Preclinical assessment of utility of M6S for multimodal acute and chronic pain treatment in diabetic neuropathyJai Shankar K Yadlapalli, Navdeep Dogra, Anqi W Walbaum, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2013
Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptorsNikhil Reddy Madadi, Narsimha Reddy Penthala, Lisa K Brents, et al.
Plos One|July 15, 2011
Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activityLisa K Brents, Emily E Reichard, Sarah M Zimmerman, et al.
ACS Chemical Neuroscience|September 30, 2020
Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor LigandsJing-Fang Yang, Alexander H Williams, Narsimha R Penthala, et al.
European Journal of Pharmacology|May 27, 2014
Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogsLirit N Franks, Benjamin M Ford, Nikhil R Madadi, et al.
Molecular Cancer Therapeutics|May 4, 2012
Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancerXinyi Liu, Indira Jutooru, Ping Lei, et al.
Pharmacology Research & Perspectives|February 1, 2020
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135)Sabrina Jones, Azure L Yarbrough, William E Fantegrossi, et al.
The American Journal of Pathology|February 19, 2013
Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injuryIn-Young Choi, Chung Ju, Angela M A Anthony Jalin, et al.
Pageof 6